Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.

Hofland J, de Herder WW, Derks L, Hofland LJ, van Koetsveld PM, de Krijger RR, van Nederveen FH, Horvath A, Stratakis CA, de Jong FH, Feelders RA.

Eur J Endocrinol. 2012 Dec 10;168(1):67-74. doi: 10.1530/EJE-12-0594. Print 2013 Jan.

2.

Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.

Lacroix A, Bourdeau I.

Endocrinol Metab Clin North Am. 2005 Jun;34(2):441-58, x. Review.

PMID:
15850852
4.

Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases.

Sasano H, Miyazaki S, Sawai T, Sasano N, Nagura H, Funahashi H, Aiba M, Demura H.

Mod Pathol. 1992 Jan;5(1):23-9.

PMID:
1542635
5.

Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?

Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA.

J Clin Endocrinol Metab. 2004 Jul;89(7):3173-82.

PMID:
15240590
6.

MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.

Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA.

Cancer Res. 2009 Apr 15;69(8):3278-82. doi: 10.1158/0008-5472.CAN-09-0155. Epub 2009 Apr 7.

7.

Primary pigmented nodular adrenocortical disease and Cushing's syndrome.

Horvath A, Stratakis C.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1238-44. Review.

8.
9.

PRKAR1A mutations in primary pigmented nodular adrenocortical disease.

Cazabat L, Ragazzon B, Groussin L, Bertherat J.

Pituitary. 2006;9(3):211-9. Review.

PMID:
17036196
10.

Primary pigmented nodular adrenocortical disease: a case report in a 7-year-old girl.

Leka S, Kousta E, Anyfandakis K, Dolianiti M, Vakaki M, Linos D, Chrousos GP, Papathanasiou A.

J Pediatr Endocrinol Metab. 2011;24(3-4):197-202.

PMID:
21648292
11.

Primary pigmented nodular adrenocortical disease.

Manipadam MT, Abraham R, Sen S, Simon A.

J Indian Assoc Pediatr Surg. 2011 Oct;16(4):160-2. doi: 10.4103/0971-9261.86881.

12.

Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.

da Silva RM, Pinto E, Goldman SM, Andreoni C, Vieira TC, Abucham J.

Pituitary. 2011 Mar;14(1):61-7. doi: 10.1007/s11102-010-0260-5.

PMID:
20924687
13.

Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.

Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X, Bertherat J.

J Clin Endocrinol Metab. 2002 Sep;87(9):4324-9.

PMID:
12213893
14.

The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.

Louiset E, Stratakis CA, Perraudin V, Griffin KJ, Libé R, Cabrol S, Fève B, Young J, Groussin L, Bertherat J, Lefebvre H.

J Clin Endocrinol Metab. 2009 Jul;94(7):2406-13. doi: 10.1210/jc.2009-0031. Epub 2009 Apr 21.

15.

Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.

Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA.

Ann Intern Med. 1999 Oct 19;131(8):585-91.

PMID:
10523219
16.

Primary pigmented nodular adrenocortical disease.

Ngow HA, Khairina WM.

Endokrynol Pol. 2011;62(3):268-70.

17.

Causes and consequences of abandoning one-stage bilateral adrenalectomy recommended in primary pigmented nodular adrenocortical disease--case presentation.

Kumorowicz-Czoch M, Dolezal-Oltarzewska K, Roztoczynska D, Chrupek M, Prokurat AI, Drabik G, Starzyk J.

J Pediatr Endocrinol Metab. 2011;24(7-8):565-7.

PMID:
21932601
18.

Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.

de Cremoux P, Rosenberg D, Goussard J, Brémont-Weil C, Tissier F, Tran-Perennou C, Groussin L, Bertagna X, Bertherat J, Raffin-Sanson ML.

Endocr Relat Cancer. 2008 Jun;15(2):465-74. doi: 10.1677/ERC-07-0081.

19.

Primary pigmented nodular adrenocortical disease presenting with a unilateral adrenocortical nodule treated with bilateral laparoscopic adrenalectomy: a case report.

Zografos GN, Pappa T, Avlonitis S, Markou A, Chrysikos DT, Kaltsas G, Aggeli C, Piaditis G.

J Med Case Rep. 2010 Jul 29;4:230. doi: 10.1186/1752-1947-4-230.

20.

Primary pigmented nodular adrenocortical disease associated with Carney complex: case report and literature review.

Gonçalves FT, Feibelmann TC, Mendes CM, Fernandes ML, Miranda GH, Gouvêa AP, Jorge PT.

Sao Paulo Med J. 2006 Nov 7;124(6):336-9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk